NCT06813664 2026-03-04
CURB-TKI
University Health Network, Toronto
Phase 2 Not yet recruiting
Clinical Trials
14 trialsNCT07413952 2026-02-17
Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases
The First Affiliated Hospital of Guangzhou Medical University
Phase 2 Not yet recruiting
NCT07358676 2026-01-22
A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT07353476 2026-01-20
Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyNâºM0 NSCLC
Shanghai Zhongshan Hospital
Phase 2 Not yet recruiting
NCT07349225 2026-01-16
Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer
The Second Affiliated Hospital of Dalian Medical University
Phase 2 Not yet recruiting
NCT07146230 2025-12-24
SPRINT 2
Montefiore Medical Center
Phase 2 Not yet recruiting
NCT07103408 2025-08-05
A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT06966583 2025-05-12
NMN
Sichuan University
Phase 1 Not yet recruiting
NCT06851819 2025-02-28
TERE
Hebei Medical University Fourth Hospital
Phase 2 Not yet recruiting
NCT06732258 2024-12-27
Low-dose Radiotherapy Combined with Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC
Sichuan University
Phase 1 Not yet recruiting
NCT06558175 2024-08-16
REPAIR
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 1 Not yet recruiting
NCT06501976 2024-07-15
An Exploratory Study of Lurbinectedin With Radiotherapy in Locally-advanced SCLC After First-line Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
NCT06236997 2024-02-01
Adebrelimab and Concurrent Radiochemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT05496166 2023-05-17
The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 3 Not yet recruiting